KEYMED BIOSCIENCES -0001 Net Asset Momentum
KEYMED BIOSCIENCES -0001 net asset momentum. KEYMED BIOSCIENCES -0001 (64Z) recorded a net asset momentum of 12.1% as of December 2025, with net assets of €2.77 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how well can KEYMED BIOSCIENCES -0001 service its debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of KEYMED BIOSCIENCES -0001 (2021–2025)
Net asset momentum of KEYMED BIOSCIENCES -0001 from 2021 to 2025. This chart tracks KEYMED BIOSCIENCES -0001's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +12.1%, with net assets of €2.77 Billion EUR as of December 2025. See 64Z net assets for net asset value and shareholders' equity analysis.
KEYMED BIOSCIENCES -0001 Net Asset Momentum by Year (2021–2025)
KEYMED BIOSCIENCES -0001 net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for KEYMED BIOSCIENCES -0001 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is KEYMED BIOSCIENCES -0001 worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €2.77 Billion | €4.22 Billion | €1.44 Billion | ▲ +12.1% |
| 2024 | €2.48 Billion | €3.77 Billion | €1.29 Billion | ▼ -17.1% |
| 2023 | €2.99 Billion | €3.88 Billion | €896.11 Million | ▼ -10.6% |
| 2022 | €3.34 Billion | €3.93 Billion | €593.10 Million | ▼ -8.4% |
| 2021 | €3.65 Billion | €3.93 Billion | €289.07 Million | — |